Review



vitro models htert bj1 telomerase fibroblasts htert  (TaKaRa)


Bioz Verified Symbol TaKaRa is a verified supplier
Bioz Manufacturer Symbol TaKaRa manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    TaKaRa vitro models htert bj1 telomerase fibroblasts htert
    Vitro Models Htert Bj1 Telomerase Fibroblasts Htert, supplied by TaKaRa, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vitro models htert bj1 telomerase fibroblasts htert/product/TaKaRa
    Average 86 stars, based on 1 article reviews
    vitro models htert bj1 telomerase fibroblasts htert - by Bioz Stars, 2026-02
    86/100 stars

    Images



    Similar Products

    96
    ATCC human normal fibroblast cell line bj1
    Human Normal Fibroblast Cell Line Bj1, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human normal fibroblast cell line bj1/product/ATCC
    Average 96 stars, based on 1 article reviews
    human normal fibroblast cell line bj1 - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    99
    ATCC normal human fibroblast bj1 cell lines
    A and B , Dose-response curves for determining the sensitivity of various human cancer cell lines to either adavosertib ( A ) or VIC-1911 ( B ) with multiple dose range (adavosertib: 0.0625-10 μmol/L; VIC-1911: 0.0313-2.5 μmol/L). Cell viability was determined after 4-day exposure to drugs by CellTiter-Glo assay. Cell viability was normalized to control cells. Data are shown as mean ± SEM. C and D , Representative images of cooperative correlation matrix (right) and Loewe plots (left) of HNSCC CAL27 cells ( C ) and NSCLC NCI-H520 cells ( D ) in combinational treatment VIC-1911/adavosertib. E , Status of TP53 mutation, Loewe synergy scores (LSS) and maximum synergistic area scores (LMSAS) of human cancer cell lines are shown for evaluating synergy of combinational VIC-1911 and adavosertib treatment using SynergyFinder. and synergy score >10 and red area indicate synergism. F and G , Dose-response curves of NHTBE ( F ) and <t>BJ1</t> ( G ) cells treated with control, adavosertib, VIC-1911 or combination from 4-day CellTiter-Glo assay. Cell viability was normalized to control cells. Shown are the means of technical triplicates from one experiment and the data as shown mean ± SEM are representative of three independent experiments with consistent results.
    Normal Human Fibroblast Bj1 Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/normal human fibroblast bj1 cell lines/product/ATCC
    Average 99 stars, based on 1 article reviews
    normal human fibroblast bj1 cell lines - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    86
    TaKaRa vitro models htert bj1 telomerase fibroblasts htert
    A and B , Dose-response curves for determining the sensitivity of various human cancer cell lines to either adavosertib ( A ) or VIC-1911 ( B ) with multiple dose range (adavosertib: 0.0625-10 μmol/L; VIC-1911: 0.0313-2.5 μmol/L). Cell viability was determined after 4-day exposure to drugs by CellTiter-Glo assay. Cell viability was normalized to control cells. Data are shown as mean ± SEM. C and D , Representative images of cooperative correlation matrix (right) and Loewe plots (left) of HNSCC CAL27 cells ( C ) and NSCLC NCI-H520 cells ( D ) in combinational treatment VIC-1911/adavosertib. E , Status of TP53 mutation, Loewe synergy scores (LSS) and maximum synergistic area scores (LMSAS) of human cancer cell lines are shown for evaluating synergy of combinational VIC-1911 and adavosertib treatment using SynergyFinder. and synergy score >10 and red area indicate synergism. F and G , Dose-response curves of NHTBE ( F ) and <t>BJ1</t> ( G ) cells treated with control, adavosertib, VIC-1911 or combination from 4-day CellTiter-Glo assay. Cell viability was normalized to control cells. Shown are the means of technical triplicates from one experiment and the data as shown mean ± SEM are representative of three independent experiments with consistent results.
    Vitro Models Htert Bj1 Telomerase Fibroblasts Htert, supplied by TaKaRa, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vitro models htert bj1 telomerase fibroblasts htert/product/TaKaRa
    Average 86 stars, based on 1 article reviews
    vitro models htert bj1 telomerase fibroblasts htert - by Bioz Stars, 2026-02
    86/100 stars
      Buy from Supplier

    96
    ATCC human skin fibroblast cell bj1
    Cytotoxicity effect of the different tested formulations at 100µg/mL on A431 and <t> Bj1 </t> cell lines and IC 50 for active compounds.
    Human Skin Fibroblast Cell Bj1, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human skin fibroblast cell bj1/product/ATCC
    Average 96 stars, based on 1 article reviews
    human skin fibroblast cell bj1 - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    86
    TaKaRa human fibroblasts htert bj1
    Cytotoxicity effect of the different tested formulations at 100µg/mL on A431 and <t> Bj1 </t> cell lines and IC 50 for active compounds.
    Human Fibroblasts Htert Bj1, supplied by TaKaRa, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human fibroblasts htert bj1/product/TaKaRa
    Average 86 stars, based on 1 article reviews
    human fibroblasts htert bj1 - by Bioz Stars, 2026-02
    86/100 stars
      Buy from Supplier

    86
    TaKaRa htert bj1 telomerase fibroblasts htert
    Cytotoxicity effect of the different tested formulations at 100µg/mL on A431 and <t> Bj1 </t> cell lines and IC 50 for active compounds.
    Htert Bj1 Telomerase Fibroblasts Htert, supplied by TaKaRa, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/htert bj1 telomerase fibroblasts htert/product/TaKaRa
    Average 86 stars, based on 1 article reviews
    htert bj1 telomerase fibroblasts htert - by Bioz Stars, 2026-02
    86/100 stars
      Buy from Supplier

    86
    TaKaRa fibroblasts bj1
    Cytotoxicity effect of the different tested formulations at 100µg/mL on A431 and <t> Bj1 </t> cell lines and IC 50 for active compounds.
    Fibroblasts Bj1, supplied by TaKaRa, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fibroblasts bj1/product/TaKaRa
    Average 86 stars, based on 1 article reviews
    fibroblasts bj1 - by Bioz Stars, 2026-02
    86/100 stars
      Buy from Supplier

    Image Search Results


    A and B , Dose-response curves for determining the sensitivity of various human cancer cell lines to either adavosertib ( A ) or VIC-1911 ( B ) with multiple dose range (adavosertib: 0.0625-10 μmol/L; VIC-1911: 0.0313-2.5 μmol/L). Cell viability was determined after 4-day exposure to drugs by CellTiter-Glo assay. Cell viability was normalized to control cells. Data are shown as mean ± SEM. C and D , Representative images of cooperative correlation matrix (right) and Loewe plots (left) of HNSCC CAL27 cells ( C ) and NSCLC NCI-H520 cells ( D ) in combinational treatment VIC-1911/adavosertib. E , Status of TP53 mutation, Loewe synergy scores (LSS) and maximum synergistic area scores (LMSAS) of human cancer cell lines are shown for evaluating synergy of combinational VIC-1911 and adavosertib treatment using SynergyFinder. and synergy score >10 and red area indicate synergism. F and G , Dose-response curves of NHTBE ( F ) and BJ1 ( G ) cells treated with control, adavosertib, VIC-1911 or combination from 4-day CellTiter-Glo assay. Cell viability was normalized to control cells. Shown are the means of technical triplicates from one experiment and the data as shown mean ± SEM are representative of three independent experiments with consistent results.

    Journal: bioRxiv

    Article Title: AURKA inhibition amplifies DNA replication stress to foster WEE1 kinase dependency and synergistic antitumor effects with WEE1 inhibition in cancers

    doi: 10.1101/2025.05.28.656693

    Figure Lengend Snippet: A and B , Dose-response curves for determining the sensitivity of various human cancer cell lines to either adavosertib ( A ) or VIC-1911 ( B ) with multiple dose range (adavosertib: 0.0625-10 μmol/L; VIC-1911: 0.0313-2.5 μmol/L). Cell viability was determined after 4-day exposure to drugs by CellTiter-Glo assay. Cell viability was normalized to control cells. Data are shown as mean ± SEM. C and D , Representative images of cooperative correlation matrix (right) and Loewe plots (left) of HNSCC CAL27 cells ( C ) and NSCLC NCI-H520 cells ( D ) in combinational treatment VIC-1911/adavosertib. E , Status of TP53 mutation, Loewe synergy scores (LSS) and maximum synergistic area scores (LMSAS) of human cancer cell lines are shown for evaluating synergy of combinational VIC-1911 and adavosertib treatment using SynergyFinder. and synergy score >10 and red area indicate synergism. F and G , Dose-response curves of NHTBE ( F ) and BJ1 ( G ) cells treated with control, adavosertib, VIC-1911 or combination from 4-day CellTiter-Glo assay. Cell viability was normalized to control cells. Shown are the means of technical triplicates from one experiment and the data as shown mean ± SEM are representative of three independent experiments with consistent results.

    Article Snippet: HNSCC (FaDu, Detroit 562, CAL27, SCC25, and SCC-9), lung cancer (NCI-H520, NCI-H358, NCI-H1437, A549, NCI-H441, NCI-H23 and NCI-H1792), ovarian cancer (A2780 and SK-OV3), pancreatic cancer (MiaPaCa-2), hepatocellular carcinoma (HepG2), and normal human fibroblast BJ1 cell lines were purchased from the American Type Culture Collection (ATCC); HNSCC SCC61 cell line was purchased from Sigma-Aldrich; the UNC7 is a patient-derived cancer cell line ( kind gift of Wendell Yarbrough, University of North Carolina ) and PCI-13 isogenic cell lines of differing TP53 including WT, null, G245D, C238F or R273H genotypes were kindly provided by Jeffrey Myers (MD Anderson Cancer Center).

    Techniques: Glo Assay, Control, Mutagenesis

    Cytotoxicity effect of the different tested formulations at 100µg/mL on A431 and  Bj1  cell lines and IC 50 for active compounds.

    Journal: Pharmaceutics

    Article Title: Transethosomal Gel for the Topical Delivery of Celecoxib: Formulation and Estimation of Skin Cancer Progression

    doi: 10.3390/pharmaceutics15010022

    Figure Lengend Snippet: Cytotoxicity effect of the different tested formulations at 100µg/mL on A431 and Bj1 cell lines and IC 50 for active compounds.

    Article Snippet: A human skin carcinoma (A431), and a normal human skin fibroblast cell (BJ1) were supplied from American Type Culture Collection (ATCC) (Manassas, VA, USA).

    Techniques: Dispersion, Negative Control, Positive Control